Habib J Dable Insider Trading $XLRN ACCELERON PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Habib J Dable.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Habib J Dable. Habib J Dable is CEO and President in ACCELERON PHARMA INC ($XLRN) and Director in Millendo Therapeutics, Inc. ($OVAS).

Habib J Dable in ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Habib J Dable: CEO and President
Holdings: 98,450 shares
Current Value: $2,337,203
Latest Transaction: Feb 02 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Habib J Dable in ACCELERON PHARMA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, XLRN, OVAS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 02 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA115.5364,3617,435,62664,361
Feb 02 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0016,662098,45081.8 K to 98.5 K (+20.37 %)
Jan 06 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS122.559411,52081,78881.9 K to 81.8 K (-0.11 %)
Jan 06 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS122.4676493,55981,88282.6 K to 81.9 K (-0.92 %)
Jan 06 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS121.55900109,39582,64683.5 K to 82.6 K (-1.08 %)
Jan 06 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS120.522,500301,30083,54686 K to 83.5 K (-2.91 %)
Jan 06 2021XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentPayment of ExerciseF124.313,278407,48886,04689.3 K to 86 K (-3.67 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseM35.0450,0001,752,000350,000
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS99.421,100109,36289,32490.4 K to 89.3 K (-1.22 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS98.574,400433,70890,42494.8 K to 90.4 K (-4.64 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS97.439,534928,89894,824104.4 K to 94.8 K (-9.14 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS96.4915,2191,468,481104,358119.6 K to 104.4 K (-12.73 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS95.8513,0471,250,555119,577132.6 K to 119.6 K (-9.84 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS94.463,000283,380132,624135.6 K to 132.6 K (-2.21 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS93.533,700346,061135,624139.3 K to 135.6 K (-2.66 %)
Jul 06 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentBuyM35.0450,0001,752,000139,32489.3 K to 139.3 K (+55.98 %)
Jan 24 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA52.9984,7204,489,31384,720
Jan 24 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0022,173089,32467.2 K to 89.3 K (+33.02 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.243,634186,20667,15170.8 K to 67.2 K (-5.13 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.26985,02370,78570.9 K to 70.8 K (-0.14 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.243,634186,20667,15170.8 K to 67.2 K (-5.13 %)
Jan 03 2020XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.26985,02370,78570.9 K to 70.8 K (-0.14 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.6734415,71070,88371.2 K to 70.9 K (-0.48 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.205,281238,70171,22776.5 K to 71.2 K (-6.90 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.6734415,71070,88371.2 K to 70.9 K (-0.48 %)
Sep 10 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.205,281238,70171,22776.5 K to 71.2 K (-6.90 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS44.231466,45876,50876.7 K to 76.5 K (-0.19 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS45.461004,54676,65476.8 K to 76.7 K (-0.13 %)
Apr 11 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS44.607,214321,74476,75484 K to 76.8 K (-8.59 %)
Jan 29 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA41.64106,4004,430,496106,400
Jan 29 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0017,700083,96866.3 K to 84 K (+26.71 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS40.85271,10366,26866.3 K to 66.3 K (-0.04 %)
Jan 04 2019XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS43.451,93083,85966,29568.2 K to 66.3 K (-2.83 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS54.3370038,03168,22568.9 K to 68.2 K (-1.02 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS53.655,607300,81668,92574.5 K to 68.9 K (-7.52 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS52.723,862203,60574,53278.4 K to 74.5 K (-4.93 %)
Dec 06 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentSellS51.542,506129,15978,39480.9 K to 78.4 K (-3.10 %)
Mar 05 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA40.61108,8004,418,368108,800
Mar 05 2018XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0018,100080,90062.8 K to 80.9 K (+28.82 %)
Dec 05 2016XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentOption ExerciseA35.04400,00014,016,000400,000
Dec 05 2016XLRNACCELERON PHARMA I ...Dable Habib JCEO and PresidentGrantA0.0062,800062,8000 to 62.8 K

Page:   1

Contact us | Follow us on Twitter